As shown in Figure 4C and D, T cell responses were completely inhibited by the addition of anti-HLA-I mAb, but not anti-HLA-II (HLA-DP mAb), which suggests that the recognition of tumor cells by SATB1565–574-specific CD8+ T cells is HLA-I restricted. Here, CD8A is linked to neoplasm.